Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3

  • Purva Bali
  • , Prince George
  • , Pamela Cohen
  • , Jianguo Tao
  • , Fei Guo
  • , Celia Sigua
  • , Anasuya Vishvanath
  • , Anna Scuto
  • , Srinivas Annavarapu
  • , Warren Fiskus
  • , Lynn Moscinski
  • , Peter Atadja
  • , Kapil Bhalla

Research output: Contribution to journal › Article › peer-review

122 Scopus citations

Fingerprint

Dive into the research topics of 'Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science